UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

URGN

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-02-03Shares Purchased (TTM):0Shares Sold (TTM):52,117

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:44,577,121Shares Outstanding:50,182,758Institutional Ownership Pct.:88.83%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Cash And Cash Equivalents At Carrying Value	110	111	90	93	104	172	125	220	131	95	119	20
Available For Sale Securities Debt Securities Curr…	30	10	37	64	92	65	125	21	33	42	28	27
Assets Current
Assets Current	237	186	169	197	237	276	295	279	197	169	182	81
Restricted Cash Current	1	1	1	1	1	1	1	1	1	1	1	1
Accounts Receivable Net Current	55	33	20	20	20	20	23	17	14	15	13	16
Inventory Net	21	16	8	7	8	9	8	7	7	6	5	5
Prepaid Expense And Other Assets Current	20	15	12	12	13	9	14	12	10	10	16	13
Assets Noncurrent
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	1
Restricted Investments Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	-	-	-	-	-	-	1	1	1	2	2	2
Available For Sale Securities Debt Securities Nonc…	-	0	0	5	5	5	5	0	0	5	7	8
Other Assets Noncurrent	7	5	7	1	0	1	0	1	1	2	2	3
Assets	254	200	185	209	248	286	302	282	201	178	194	95
Accounts Payable And Accrued Liabilities Current	35	28	26	31	30	27	20	24	18	17	14	16
Liabilities Current
Liabilities Current	51	46	42	48	42	46	33	34	26	31	26	27
Employee Related Liabilities Current	10	14	11	12	7	11	9	7	5	11	8	7
Other Liabilities Current	5	5	5	5	5	8	4	4	3	4	4	4
Long Term Debt Noncurrent	190	122	122	123	122	122	122	98	98	99	99	98
Liabilities Noncurrent
Operating Lease Liability Noncurrent	-	-	-	-	-	-	0	0	1	1	1	1
Liability For Uncertain Tax Positions Noncurrent	4	4	4	4	4	4	3	3	3	3	3	3
Liabilities	378	306	300	302	294	295	276	252	241	244	236	234
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	859	854	818	806	803	797	794	775	671	614	611	493
Stockholders Equity
Stockholders Equity	-124	-105	-115	-93	-46	-9	26	30	-40	-65	-42	-138
Retained Earnings Accumulated Deficit	-983	-960	-933	-900	-850	-806	-769	-745	-712	-679	-653	-631
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	-0	-0	0	-0	-0
Liabilities And Stockholders Equity	254	200	185	209	248	286	302	282	201	178	194	95
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	49	48	47	46	46	42	42	41	36	32	31	23
Shares Outstanding	49	48	47	46	46	42	42	41	36	32	42	47

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.16%	-	-	-	-	-	-	-	-	-	-	-
2025	-33.84%	21.90%	74.15%	4.63%	-1.34%	2.04%	22.39%	-2.17%	-15.04%	-9.73%	26.76%	51.89%
2024	1.07%	21.50%	19.97%	-11.56%	-15.11%	-18.45%	3.76%	-12.09%	-16.34%	3.33%	16.03%	-57.26%
2023	-21.58%	-16.67%	82.05%	-14.47%	-33.95%	-47.85%	22.17%	18.24%	41.01%	-5.09%	-0.21%	-7.19%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.69	4.01	3.99	4.14	5.65	6.01	9.00	8.15	7.47	5.42	7.06	3.04
Quick Ratio	3.89	3.34	3.51	3.74	5.16	5.62	8.34	7.58	6.80	4.91	6.25	2.38
Working Capital	186.83M	139.61M	126.30M	149.32M	195.18M	230.19M	262.31M	244.75M	170.42M	137.97M	156.34M	54.57M
Leverage & Debt
Debt to Equity	-3.04	-2.90	-2.60	-3.24	-6.33	-33.46	10.83	8.30	-6.00	-3.73	-5.61	-1.69
Interest Coverage TTM	-7.00	-8.14	-8.63	-8.34	-7.63	-7.73	-6.85	-5.99	-5.09	-4.45	-4.96	-5.73
Debt Ratio	1.49	1.53	1.62	1.45	1.19	1.03	0.92	0.89	1.20	1.37	1.22	2.45
Efficiency & Turnover
Asset Turnover TTM	0.56	0.45	0.40	0.38	0.41	0.39	0.60	0.76	0.92	0.90	0.48	0.60
Days Sales Outstanding TTM	97.49	88.74	80.37	71.78	67.14	72.16	43.80	41.67	33.90	36.20	52.61	68.20
Receivables Turnover TTM	3.74	4.11	4.54	5.09	5.44	5.06	8.33	8.76	10.77	10.08	6.94	5.35
Per Share Metrics
Free Cash Flow Per Share TTM	-3.31	-3.38	-2.87	-2.59	-2.26	-2.26	-2.06	-2.12	-2.23	-2.66	-2.64	-3.65
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	89.85%	88.66%	87.95%	88.54%	89.68%	90.18%	89.38%	89.12%	88.92%	88.42%	87.92%	87.60%
Operating Profit Margin TTM	-77.02%	-113.73%	-138.22%	-131.12%	-117.51%	-107.06%	-56.37%	-55.26%	-48.25%	-46.19%	-92.15%	-104.52%
Net Profit Margin TTM	-94.83%	-139.81%	-170.59%	-164.44%	-150.68%	-140.35%	-128.99%	-131.64%	-125.83%	-125.78%	-136.00%	-150.37%
Growth Metrics
Net Revenue Growth (1Y)	52.92%	21.45%	-35.03%	-34.64%	-35.97%	-36.29%	92.23%	98.83%	111.05%	120.48%	23.76%	25.70%
Net Income Growth (1Y)	-3.76%	20.98%	-14.07%	-18.36%	-23.33%	-28.91%	82.31%	74.06%	61.77%	62.57%	-3.90%	-4.13%
EPS Growth (1Y)	-9.06%	7.81%	-16.36%	-30.74%	-40.08%	-52.19%	25.88%	0.83%	1.62%	28.58%	-32.17%	-7.23%
Valuation Metrics
P/E TTM	-6.77	-7.34	-5.82	-4.22	-3.79	-3.60	-3.10	-3.58	-3.08	-2.42	-4.31	-2.23
P/B	-7.26	-10.68	-8.31	-7.00	-11.29	-51.87	23.28	22.42	-13.85	-6.63	-10.78	-1.75
P/S TTM	6.42	10.26	9.93	6.94	5.71	5.05	4.00	4.71	3.87	3.05	5.86	3.35
Market Cap	902.29M	1.13B	958.74M	654.04M	524.49M	456.64M	594.10M	679.61M	555.89M	432.51M	452.50M	242.83M
Enterprise Value	981.85M	1.14B	990.82M	683.64M	542.56M	406.38M	590.89M	557.45M	522.04M	436.06M	431.71M	321.00M
Calculated Values
Free Cash Flow TTM	-166.04M	-162.73M	-138.13M	-123.53M	-107.39M	-97.06M	-96.38M	-86.02M	-82.48M	-76.57M	-85.28M	-85.65M
Net Debt	79.56M	11.47M	32.07M	29.60M	18.08M	-50.25M	-3.21M	-122.16M	-33.85M	3.55M	-20.79M	78.17M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-03Sale

Owner: Smith, Jason Drew

Title: General Counsel

Shares: 7,479

Price/Share: $19.69

Value: $147,261.51

Shares Owned: 51,326

Relationship: Officer

Ownership: Direct

2026-02-03Sale

Owner: Schoenberg, Mark

Title: Chief Medical Officer

Shares: 7,373

Price/Share: $19.69

Value: $145,174.37

Shares Owned: 144,985

Relationship: Officer

Ownership: Direct

2025-11-19Sale

Owner: Schoenberg, Mark

Title: Chief Medical Officer

Shares: 10,000

Price/Share: $25.00

Value: $250,000.00

Shares Owned: 139,025

Relationship: Officer

Ownership: Direct

2025-10-08Sale

Owner: Degnan, Chris

Title: Chief Financial Officer

Shares: 2,203

Price/Share: $16.85

Value: $37,120.55

Shares Owned: 2,280

Relationship: Officer

Ownership: Direct

2025-09-08Sale

Owner: Schoenberg, Mark

Title: Chief Medical Officer

Shares: 871

Price/Share: $19.11

Value: $16,644.81

Shares Owned: 149,025

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-03	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	7,479	19.69	$147,261.51	51,326	4
2026-02-03	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	7,373	19.69	$145,174.37	144,985	4
2025-11-19	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	10,000	25.00	$250,000.00	139,025	4
2025-10-08	Degnan, Chris	Officer	Chief Financial Officer	Direct	Sale	2,203	16.85	$37,120.55	2,280	4
2025-09-08	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	871	19.11	$16,644.81	149,025	4
2025-09-08	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	1,520	19.11	$29,047.20	43,305	4
2025-08-11	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	10,000	17.69	$176,900.00	148,229	4
2025-07-28	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	5,149	19.14	$98,551.86	158,229	4
2025-07-28	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	7,522	19.14	$143,971.08	41,492	4
2025-06-09	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	5,162	7.37	$38,043.94	153,378	4
2025-01-31	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	7,379	11.14	$82,202.06	26,468	4
2025-01-31	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	4,551	11.14	$50,698.14	145,666	4
2024-09-09	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	859	13.08	$11,235.72	145,091	4
2024-09-09	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	1,521	13.08	$19,894.68	25,226	4
2024-06-10	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	5,153	13.08	$67,401.24	144,284	4
2024-03-18	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	12,000	14.05	$168,600.00	139,437	4
2024-02-01	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	4,993	15.78	$78,789.54	18,824	4/A
2024-02-01	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	3,789	15.78	$59,790.42	149,423	4/A
2024-01-31	Schoenberg, Mark	Officer	Chief Medical Officer	Direct	Sale	3,789	15.74	$59,638.86	149,423	4
2024-01-31	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	4,993	15.74	$78,589.82	18,824	4
2023-08-31	Smith, Jason Drew	Officer	General Counsel	Direct	Sale	3,800	18.01	$68,438.00	18,407	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

2026-03-31

88.83%

Inst. Shares: 44,577,121

Shares Outstanding: 50,182,758

2025-12-31

84.52%

Inst. Shares: 40,665,674

Shares Outstanding: 48,116,098

2025-09-30

86.02%

Inst. Shares: 41,341,000

Shares Outstanding: 48,057,386

2025-06-30

77.19%

Inst. Shares: 36,850,676

Shares Outstanding: 47,739,816

2025-03-31

83.94%

Inst. Shares: 39,807,202

Shares Outstanding: 47,422,119

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	44,577,121	50,182,758	88.83%
2025-12-31	40,665,674	48,116,098	84.52%
2025-09-30	41,341,000	48,057,386	86.02%
2025-06-30	36,850,676	47,739,816	77.19%
2025-03-31	39,807,202	47,422,119	83.94%
2024-12-31	34,508,102	42,876,737	80.48%
2024-09-30	33,725,917	46,779,637	72.10%
2024-06-30	36,930,154	40,501,315	91.18%
2024-03-31	25,330,682	37,059,186	68.35%
2023-12-31	19,577,474	28,834,303	67.90%
2023-09-30	15,644,387	32,298,182	48.44%
2023-06-30	10,680,332	23,462,016	45.52%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.